International Journal of Nanomedicine (Aug 2024)
Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications
Abstract
Nasrul Wathoni,1,* Cecep Suhandi,1,* Khaled M Elamin,2,* Ronny Lesmana,3,4,* Nurhasni Hasan,5,* Ahmed Fouad Abdelwahab Mohammed,6,* Ali El-Rayyes,7,* Gofarana Wilar8,* 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia; 2Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan; 3Physiology Division, Department of Biomedical Science, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; 4Biological Activity Division, Central Laboratory, Universitas Padjadjaran, Bandung, Indonesia; 5Department of Pharmacy Science and Technology, Faculty of Pharmacy, Universitas Hasanuddin, Makassar, 90245, Indonesia; 6Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt; 7Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia; 8Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia*These authors contributed equally to this workCorrespondence: Nasrul Wathoni, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia, Tel +62-22-842-888-888, Email [email protected]: The current treatments for wound healing still exhibit drawbacks due to limited availability at the action sites, susceptibility to degradation, and immediate drug release, all of which are detrimental in chronic conditions. Nano-modification strategies, offering various advantages that can enhance the physicochemical properties of drugs, have been employed in efforts to maximize the efficacy of wound healing medications. Nowadays, nanostructured lipid carriers (NLCs) provide drug delivery capabilities that can safeguard active compounds from environmental influences and enable controlled release profiles. Consequently, NLCs are considered an alternative therapy to address the challenges encountered in wound treatment. This review delves into the application of NLCs in drug delivery for wound healing, encompassing discussions on their composition, preparation methods, and their impact on treatment effectiveness. The modification of drugs into the NLC model can be facilitated using relatively straightforward technologies such as pressure-based processes, emulsification techniques, solvent utilization methods, or phase inversion. Moreover, NLC production with minimal material compositions can accommodate both single and combination drug delivery. Through in vitro, in vivo, and clinical studies, it has been substantiated that NLCs can enhance the therapeutic potential of various drug types in wound healing treatments. NLCs enhance efficacy by reducing the active substance particle size, increasing solubility and bioavailability, and prolonging drug release, ensuring sustained dosage at the wound site for chronic wounds. In summary, NLCs represent an effective nanocarrier system for optimizing the bioavailability of active pharmacological ingredients in the context of wound healing. Keywords: drug delivery, nanocarrier, nanostructured lipid carriers, wound healing